Pulse Oximetry Screening for Critical Congenital Heart Disease: Bringing Evidence Into Practice

Amsbaugh, Sarah; Scott, Shannon D.; Foss, Karen

doi:10.1016/j.pedn.2014.10.013

Cited by 9 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of deaths from CHD per day reported for different ages indicates the importance of the first week of life as a critical period, when the majority of deaths from CHD occurred, and particularly the first day of life. This situation should enable specialized health teams to design and plan strategies to determine diagnoses during prenatal and early neonatal periods and to provide effective and timely care [ 32 ]. To improve the life expectancy of patients with CHD, modern intensive care units are needed as well as health personnel trained to manage them.…”

Section: Discussionmentioning

confidence: 99%

Mortality from Congenital Heart Disease in Mexico: A Problem on the Rise

et al. 2016

View full text Add to dashboard Cite

Background and ObjectivesTemporal trends in mortality from congenital heart disease (CHD) vary among regions. It is therefore necessary to study this problem in each country. In Mexico, congenital anomalies were responsible for 24% of infant mortality in 2013 and CHD represented 55% of total deaths from congenital anomalies among children under 1 year of age. The objectives of this study were to analyze the trends in infant mortality from CHD in Mexico (1998 to 2013), its specific causes, age at death and associated socio-demographic factors.MethodsPopulation-based study which calculated the compounded annual growth rate of death rom CHD between 1998 and 2013. Specific causes, age at which death from CHD occurred and risk factors associated with mortality were analyzed for the year 2013.ResultsInfant mortality from CHD increased 24.8% from 1998 to 2013 (114.4 to 146.4/ 100,000 live births). A total of 3,593 CHD deaths occurred in 2013; the main causes were CHD with left-to-right shunt (n = 487; 19.8/100,000 live births) and cyanotic heart disease (n = 410; 16.7/100,000). A total of 1,049 (29.2%) deaths from CHD occurred during the first week of life. Risk factors associated with mortality from CHD were, in order of magnitude: non-institutional birth, rural area, birth in a public hospital and male sex.ConclusionsMortality from CHD has increased in Mexico. The main causes were CHD with left-to-right shunt, which are not necessarily fatal if treated promptly. Populations vulnerable to death from CHD were identified. Approximately one-third of the CHD occurred during the first week of life. It is important to promote early diagnosis, especially for non-institutional births.

show abstract

Section: Discussionmentioning

confidence: 99%

Mortality from Congenital Heart Disease in Mexico: A Problem on the Rise

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Although the advantages of CCHD screening are well recognized, when compared with developed countries, challenges to the implementation of screening certainly exist. 20 The first issue of note is burden of resources,…”

Section: The Current Chd Screening Strategy Is Feasiblementioning

confidence: 99%

Pulse Oximetry and Auscultation for Congenital Heart Disease Detection

Zhao

et al. 2017

Pediatrics

View full text Add to dashboard Cite

show abstract

“…Pulse oximetry is easily accessible, inexpensive, and noninvasive and can be easily performed by the nurses at the infant's bedside; however, it remains a technology that is underutilized in newborns. [ 5 ]…”

Section: Screening With Pulse Oximetrymentioning

confidence: 99%

Critical congenital heart disease screening

Chamsi-Pasha

Chamsi‐Pasha

2016

Avicenna J Med

View full text Add to dashboard Cite

Critical congenital heart disease (CCHD) is a heart lesion for which neonates require early surgical intervention to survive. Without intervention, the rates of mortality and survival with significant disability are extremely high. Early diagnosis can potentially improve health outcomes in newborns with CCHD. Until recent years, no routine screening protocol existed. In the last few years, pulse oximetry screening for CCHD in newborns has been added to the list of recommended uniform screening panels and advocated by several health-care authorities. A positive screening test result warrants an echocardiogram to evaluate for CCHD. Newborn screens do not usually require parental consent. However, most of the states mandates in the United States include a statement allowing exemption from the screen on the basis of parental religious or personal beliefs.

show abstract

Pulse Oximetry Screening for Critical Congenital Heart Disease: Bringing Evidence Into Practice

Cited by 9 publications

References 19 publications

Mortality from Congenital Heart Disease in Mexico: A Problem on the Rise

Mortality from Congenital Heart Disease in Mexico: A Problem on the Rise

Pulse Oximetry and Auscultation for Congenital Heart Disease Detection

Critical congenital heart disease screening

Contact Info

Product

Resources

About